Aortic valve sclerosis is associated with lower serum adiponectin levels. Issue 6 (June 2015)
- Record Type:
- Journal Article
- Title:
- Aortic valve sclerosis is associated with lower serum adiponectin levels. Issue 6 (June 2015)
- Main Title:
- Aortic valve sclerosis is associated with lower serum adiponectin levels
- Authors:
- Çabuk, Gizem
Guray, Umit
Kafes, Habibe
Guray, Yesim
Cabuk, Ali Kemal
Bayir, Pinar T.
Asarcikli, Lale D. - Abstract:
- <abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Aims</title> <p>The sclerotic lesions of the aortic valve share common features with atherosclerosis. An anti-inflammatory protein, adiponectin, seems to have a protective effect on the cardiovascular system. The goal of our study is to determine adiponectin levels in patients with aortic sclerosis and to compare these values with the control group with similar age and cardiovascular risk profile.</p> </sec> <sec> <title>Methods</title> <p>Sixty-eight patients with aortic sclerosis and 40 controls were included. Serum adiponectin levels were measured by solid-phase enzyme-linked immunosorbent assay.</p> </sec> <sec> <title>Results</title> <p>There were no significant differences regarding age, sex and other cardiovascular risk factors between groups. Also, mean body mass index values were similar. The rate of mitral annular calcification and left ventricular hypertrophy were significantly higher in patients with aortic sclerosis. Among laboratory variables, high-sensitive C-reactive protein (hsCRP) levels were significantly higher in patients with aortic sclerosis than in those without (4.0 ± 2.9 vs. 2.9 ± 2.3 mg/dl, <italic>P</italic> = 0.04). Adiponectin levels were found to be significantly lower in aortic sclerosis group than in controls (9.7 ± 4.4 vs. 11.7 ± 4.9 μg/ml, <italic>P</italic> = 0.034). In the whole group, adiponectin levels were significantly correlated with BMI<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Aims</title> <p>The sclerotic lesions of the aortic valve share common features with atherosclerosis. An anti-inflammatory protein, adiponectin, seems to have a protective effect on the cardiovascular system. The goal of our study is to determine adiponectin levels in patients with aortic sclerosis and to compare these values with the control group with similar age and cardiovascular risk profile.</p> </sec> <sec> <title>Methods</title> <p>Sixty-eight patients with aortic sclerosis and 40 controls were included. Serum adiponectin levels were measured by solid-phase enzyme-linked immunosorbent assay.</p> </sec> <sec> <title>Results</title> <p>There were no significant differences regarding age, sex and other cardiovascular risk factors between groups. Also, mean body mass index values were similar. The rate of mitral annular calcification and left ventricular hypertrophy were significantly higher in patients with aortic sclerosis. Among laboratory variables, high-sensitive C-reactive protein (hsCRP) levels were significantly higher in patients with aortic sclerosis than in those without (4.0 ± 2.9 vs. 2.9 ± 2.3 mg/dl, <italic>P</italic> = 0.04). Adiponectin levels were found to be significantly lower in aortic sclerosis group than in controls (9.7 ± 4.4 vs. 11.7 ± 4.9 μg/ml, <italic>P</italic> = 0.034). In the whole group, adiponectin levels were significantly correlated with BMI (<italic>r</italic> = −0.22, <italic>P</italic> = 0.02), white blood cell count (<italic>r</italic> = −0.2, <italic>P</italic> = 0.03), hsCRP (<italic>r</italic> = −0.25, <italic>P</italic> = 0.008), total cholesterol (<italic>r</italic> = −0.18, <italic>P</italic> = 0.05), high-density lipoprotein (HDL) cholesterol (<italic>r</italic> = 0.31, <italic>P</italic> = 0.001) and triglyceride (<italic>r</italic> = −0.36, <italic>P</italic> &lt; 0.001).</p> </sec> <sec> <title>Conclusion</title> <p>In patients with aortic sclerosis, serum adiponectin levels were significantly lower compared with those with normal aortic valves. Our findings suggested that adiponectin might play a role in the progression of degenerative aortic valve disease.</p> </sec> </abstract> … (more)
- Is Part Of:
- Journal of cardiovascular medicine. Volume 16:Issue 6(2015:Jun.)
- Journal:
- Journal of cardiovascular medicine
- Issue:
- Volume 16:Issue 6(2015:Jun.)
- Issue Display:
- Volume 16, Issue 6 (2015)
- Year:
- 2015
- Volume:
- 16
- Issue:
- 6
- Issue Sort Value:
- 2015-0016-0006-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-06
- Subjects:
- Cardiology -- Periodicals
Cardiovascular system -- Diseases -- Periodicals
Cardiology -- Periodicals
Cardiovascular Diseases -- Periodicals
616.1005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=01244665-000000000-00000 ↗
http://www.jcardiovascularmedicine.com/pt/re/jcm/home.htm ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.2459/JCM.0000000000000137 ↗
- Languages:
- English
- ISSNs:
- 1558-2027
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.867300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4182.xml